Boston Children's Hospital
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1869-01-01
- Employees
- -
- Market Cap
- -
Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
Phase 4
Completed
- Conditions
- Attention Deficit Disorder With HyperactivityEpilepsy
- Interventions
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2013-08-01
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT00323947
- Locations
- 🇺🇸
Childrens Hospital Boston, Boston, Massachusetts, United States
Popular Diets Study
Not Applicable
Completed
- Conditions
- ObesityInsulin Resistance
- Interventions
- Other: Low glycemic index dietOther: Low fat dietOther: Very low carbohydrate diet
- First Posted Date
- 2006-04-18
- Last Posted Date
- 2016-11-23
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT00315354
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Phase 2
Completed
- Conditions
- Anorexia Nervosa
- Interventions
- Other: Placebo (Sugar Pill)Drug: Hormone replacement therapy (estrogen/progestin)
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2018-04-11
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT00310791
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
Adolescents Born Preterm; Nurtured Beginnings
Not Applicable
- Conditions
- Preterm Birth
- Interventions
- Behavioral: Individualized Developmental Care in the NICU
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT00310869
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
Characterization of Angelman Syndrome
Completed
- Conditions
- Angelman Syndrome
- First Posted Date
- 2006-02-27
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 302
- Registration Number
- NCT00296764
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio, United States
🇺🇸Rady Children's Hospital San Diego, San Diego, California, United States
Nesiritide Use Following Cardiac Surgery in Infants
Phase 1
Terminated
- Conditions
- Cardiopulmonary BypassHeart Defects, Congenital
- Interventions
- Drug: Placebo
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT00281671
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
Alendronate Osteoporosis Study
Phase 2
Completed
- Conditions
- Glucocorticoid-Associated Osteopenia and Osteoporosis
- First Posted Date
- 2006-01-16
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT00277251
Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia
Phase 1
Completed
- Conditions
- Fanconi Anemia
- Interventions
- Genetic: Retrovirus Construct
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2017-06-23
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 3
- Registration Number
- NCT00272857
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Molecular and Genetic Studies of Congenital Myopathies
Recruiting
- Conditions
- Undefined Congenital MyopathyCentronuclear MyopathyCongenital Fiber Type DisproportionMultiminicore DiseaseRigid Spine Muscular DystrophyCentral Core DiseaseNemaline MyopathyMyotubular Myopathy
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 4000
- Registration Number
- NCT00272883
- Locations
- 🇺🇸
Genetics Division, Boston Children's Hospital, Boston, Massachusetts, United States
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
Phase 1
Completed
- Conditions
- Smith-Lemli-Opitz Syndrome
- Interventions
- Drug: crystalline cholesterol oil-based suspension
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Boston Children's Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT00272844
- Locations
- 🇺🇸
Children's Hospital Boston, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath